There are no adequate data from the use of ranolazine in pregnant women. Animal studies are insufficient with respect to effects on pregnancy and embryo foetal development. The potential risk for humans is unknown. Ranolazine should not be used during pregnancy unless clearly necessary.
Lactation: It is unknown whether ranolazine is excreted in human breast milk. The excretion of ranolazine in milk has not been studied in animals. Cartinex should not be used during breast-feeding.